The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

PRTC PURETECH HEALTH PLC ORD 1P




Fundamentals data is provided by FTSE Russell Data Solutions. To provide comparable issuer data, information has been standardised by FTSE Russell Data Solutions using globally adopted XBRL taxonomies. The data presented may therefore differ from an issuer's annual report and 'as reported' data should be obtained directly from the source issuer.

Data is provided "AS IS", with all faults, and on an "AS AVAILABLE" basis for information purposes only. London Stock Exchange is not liable for any errors, omissions or other defects in the data, or for any decisions taken in reliance of the data. Please see our full disclaimer here: https://www.londonstockexchange.com/global/legal/disclaimer.htm
Income Statement 31-Dec-14
( $ m )
31-Dec-15
( $ m )
31-Dec-16
( $ m )
31-Dec-17
( $ m )
Continuing Operations
Revenue  2.22 11.83 4.43 2.54
Operating Profit/(Loss)  -17.44 -43.64 -73.93 -115.42
Net Interest  n/a n/a n/a n/a
Profit Before Tax  -76.22 -56.32 -83.18 -53.10
Profit After Tax  -75.94 -58.24 -81.61 -53.09
Discontinued Operations
Profit After Tax  n/a n/a n/a n/a
PROFIT FOR THE PERIOD  -75.94 -58.24 -81.61 -70.70
Attributable to:
Minority Interests  34.30 18.85 32.82 101.57
Equity Holders of Parent Company  -41.64 -39.39 -48.79 30.87
 
Continuing EPS
Earnings per Share - Basic  -51.00¢ -21.00¢ -21.00¢ 13.00¢
Earnings per Share - Diluted  -51.00¢ -21.00¢ -21.00¢ 13.00¢
Earnings per Share - Adjusted  n/a n/a n/a n/a
Continuing and Discontinued EPS
Earnings per Share - Basic  -51.00¢ -21.00¢ -21.00¢ 13.00¢
Earnings per Share - Diluted  -51.00¢ -21.00¢ -21.00¢ 13.00¢
Earnings per Share - Adjusted  n/a n/a n/a n/a
 
Dividend per Share  n/a n/a n/a n/a

Balance Sheet 31-Dec-14
( $ m )
31-Dec-15
( $ m )
31-Dec-16
( $ m )
31-Dec-17
( $ m )
Assets
Non-Current Assets
Property, Plant & Equipment  1.23 4.52 6.92 6.86
Intangible Assets  3.00 3.87 3.52 3.31
Investment Properties  n/a n/a n/a n/a
Investments  0.08 0.11 0.08 131.35
Other Financial Assets  n/a n/a n/a n/a
Other Non-Current Assets  0.00 0.06 0.06 0.07
  4.31 8.55 10.60 141.74
Current Assets
Inventories  n/a n/a n/a n/a
Trade & Other Receivables  1.75 0.71 0.12 1.80
Cash at Bank & in Hand  61.96 134.75 62.96 72.65
Current Asset Investments  1.17 179.78 219.41 117.02
Other Current Assets  1.84 2.96 5.66 6.64
  66.72 318.20 288.15 198.11
 
Total Assets  71.03 326.76 298.75 339.85
 
Liabilities
Current Liabilities
Borrowings  6.95 4.96 6.95 7.46
Other Current Liabilities  81.99 148.35 186.01 250.05
  93.67 160.52 204.08 273.86
 
Net Current Assets  -26.95 157.68 84.07 -75.75
 
Non-Current Liabilities
Borrowings  0.00 0.00 0.00 0.00
Provisions  n/a n/a n/a n/a
Other Non-Current Liabilities  0.11 1.89 2.06 1.83
  0.67 2.18 2.26 1.99
 
Other Liabilities  n/a n/a n/a n/a
Total Liabilities  49.02 100.63 121.08 125.54
 
Net Assets  22.00 226.12 177.67 214.30
 
Capital & Reserves
Share Capital  2.36 4.52 4.61 4.68
Share Premium Account  n/a 181.74 181.66 181.59
Other Reserves  n/a n/a n/a n/a
Retained Earnings  -70.42 -111.42 -160.34 -127.87
Shareholders Funds  22.00 226.12 177.67 214.30
 
Minority Interests/Other Equity  -45.32 -62.07 -85.26 -150.30
Total Equity *   -23.31 164.05 92.41 64.00

Ratios - based on IFRS 31-Dec-14 31-Dec-15 31-Dec-16 31-Dec-17
Continuing Operations
PE Ratio *   n/a n/a n/a 15.46
PEG *   n/a n/a n/a n/a
Earnings per Share Growth  n/a n/a n/a n/a
Dividend Cover *   n/a n/a n/a n/a
Revenue Per Share  2.69¢ 6.38¢ 1.93¢ 1.08¢
Pre-Tax Profit per Share  -92.44¢ -30.40¢ -36.14¢ -22.55¢
Operating Margin  -785.10% -368.97% -1668.45% -4553.06%
Return on Capital Employed  n/a -33.57% -35.47% -56.80%
 
Continuing & Discontinued Operations
Dividend Yield *   n/a n/a n/a n/a
Dividend per Share Growth  n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  16.09¢ 98.27¢ 74.83¢ 88.67¢
Net Gearing *   -250.01% -57.40% -31.52% -30.42%

Data provided by FTSE Russell


Market

Company Information
Company website http://www.puretechheal...
Company address 501 Boylston Street, Suite 6102, Boston, 02116, United States
FTSE ICB sector Pharmaceuticals, Biotechnology and Marijuana Producers
FTSE ICB subsector Biotechnology
Company market cap, £m* 718.86
Admission date 19 Jun 2015
*The company market capitalization reflects the London listed element of Ordinary and Preference shares only and is approximate. Data provided by FTSE Russell.


Security Information
FTSE index FTSE 250,FTSE MID 250 (ex IT),FTSE 350,FTSE 350 Low Yield,FTSE 350 (ex IT),FTSE All-Share,FTSE All-Share (ex IT)
Market Main Market
Market identifier code (MIC) XLON
Trading service SETS
Trading segment STMM
Listing category Premium Equity Commercial Companies
Country of share register GB
ISIN GB00BY2Z0H74
SEDOL BY2Z0H7
Exchange market size 3,000
Security market cap, £m 718.86
*The market capitalisation of the security reflects data from previous trading day.


PURETECH share fundamentals (PRTC)